Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.
A team of researchers examined the association between combined hormonal contraceptive use in women and its protection against musculoskeletal conditions and injuries.
Researchers conducted an observational study that examined the likelihood of newborns and infants having measles antibodies passed down from their mothers.
This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...
According to a study, pregnant women without a previous diagnosis of hypertension developed postpartum hypertension—some more than 6 weeks after delivery.
Menopausal symptoms are relevant for primary care clinicians because many patients, like the “Baby Boomers and the Generation X” populations, are aging in the United States. This article summarizes a...
